EAM Investors, LLC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,573,740
+1.0%
79,905
-15.4%
0.51%
-8.7%
Q3 2022$2,549,000
+138.4%
94,413
+122.0%
0.55%
+119.0%
Q3 2020$1,069,000
+38.8%
42,537
+34.8%
0.25%
+48.8%
Q2 2020$770,000
-39.0%
31,552
-63.0%
0.17%
-56.6%
Q1 2020$1,262,000
-26.2%
85,302
-19.1%
0.39%
+4.3%
Q4 2019$1,711,000
-50.9%
105,429
-6.8%
0.38%
-35.2%
Q1 2018$3,483,000
-9.2%
113,096
+5.4%
0.58%
-15.6%
Q4 2017$3,837,000
+92.0%
107,333
+48.0%
0.69%
+158.3%
Q3 2017$1,998,000
+123.2%
72,518
+113.9%
0.27%
+79.7%
Q2 2017$895,000
-74.5%
33,897
-67.0%
0.15%
-67.8%
Q4 2015$3,512,000
+96.1%
102,800
+95.2%
0.46%
+35.0%
Q2 2014$1,791,00052,6680.34%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$156,130,00032.47%
Camber Capital Management LP 630,000$21,420,0001.40%
Granite Point Capital Management, L.P. 50,000$1,700,0001.17%
Rhenman & Partners Asset Management AB 82,000$2,788,0000.83%
Geduld E E 25,001$850,0000.53%
Pier Capital, LLC 106,985$3,637,0000.52%
Ghost Tree Capital, LLC 20,000$680,0000.48%
ArrowMark Colorado Holdings LLC 433,457$14,738,0000.42%
Polar Capital LLP 577,042$19,618,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,500$8,721,0000.35%
View complete list of REVANCE THERAPEUTICS INC shareholders